Quest Diagnostics (DGX) Tops Q4 EPS by 4c; Guides Above the Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Wells Fargo Downgrades Quest Diagnostics (DGX) to Underperform
January 30, 2015 7:08 AM ESTWells Fargo downgraded Quest Diagnostics (NYSE: DGX) from Market Perform to Underperform with a price target of $60-$65. Analyst Gary Lieberman said thinks investors should view the expense associated with the Invigorate savings initiative as ongoing.
For an analyst ratings summary and... More
Quest Diagnostics (DGX) Raises Quarterly Dividend 15.2% to $0.38; 2.2% Yield
January 29, 2015 7:54 AM ESTQuest Diagnostics (NYSE: DGX) declared a quarterly dividend of $0.38 per share, or $1.52 annualized. This is a 15.2% increase from the prior dividend of $0.33.
The dividend will be payable on April 22, 2015, to stockholders of record on April 8, 2015, with an ex-dividend date of April 6,... More
